Engineering clinically-relevant human fibroblastic cell-derived extracellular matrices

被引:18
|
作者
Franco-Barraza, Janusz [1 ]
Raghavan, Kristopher S. [1 ,2 ]
Luong, Tiffany [1 ]
Cukierman, Edna [1 ]
机构
[1] Fox Chase Canc Ctr, Martin & Concetta Greenberg Pancreat Canc Inst, Canc Biol, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[2] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
来源
CELL-DERIVED MATRICES, PT A | 2020年 / 156卷
关键词
CANCER-ASSOCIATED FIBROBLASTS; TUMOR-ASSOCIATED FIBROBLASTS; STROMAL FIBROBLASTS; GROWTH; MICROENVIRONMENT; PROLIFERATION; STROMAGENESIS; MAINTENANCE; ACTIVATION; MIGRATION;
D O I
10.1016/bs.mcb.2019.11.014
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Three-dimensional (3D) culturing models, replicating in vivo tissue microenvironments that incorporate native extracellular matrix (ECM), have revolutionized the cell biology field. Fibroblastic cells generate lattices of interstitial ECM proteins. Cell interactions with ECMs and with molecules sequestered/stored within these are crucial for tissue development and homeostasis maintenance. Hence, ECMs provide cells with biochemical and biomechanical cues to support and locally control cell function. Further, dynamic changes in ECMs, and in cell-ECM interactions, partake in growth, development, and temporary occurrences such as acute wound healing. Notably, dysregulation in ECMs and fibroblasts could be important triggers and modulators of pathological events such as developmental defects, and diseases associated with fibrosis and chronic inflammation such as cancer. Studying the type of fibroblastic cells producing these matrices and how alterations to these cells enable changes in ECMs are of paramount importance. This chapter provides a step-by-step method for producing multilayered (e.g., 3D) fibroblastic cell-derived matrices (fCDM). Methods also include means to assess ECM topography and other cellular traits, indicative of fibroblastic functional statuses, like naive/normal vs. inflammatory and/or myofibroblastic. For these, protocols include indications for isolating normal and diseased fibroblasts (i.e., cancer-associated fibroblasts known as CAFs). Protocols also include means for conducting microscopy assessments, querying whether fibroblasts present with fCDM-dependent normal or CAF phenotypes. These are supported by discrete semi-quantitative digital imaging analyses, providing some imaging processing advice. Additionally, protocols include descriptions for effective fCDM decellularization, which renders cellular debris-free patho/physiological in vivo-like scaffolds, suitable as 3D substrates for subsequent cell culturing.
引用
收藏
页码:109 / 160
页数:52
相关论文
共 50 条
  • [41] Requirements for human mesenchymal stem cell-derived small extracellular vesicles
    Li, Qing
    Li, Bo
    Ye, Teng
    Xu, Wenrong
    Yin, Hang
    Deng, Zhifeng
    Li, Haiyan
    Yan, Xiaomei
    Hao, Xiaoke
    Li, Li
    Tao, Zhihua
    Liu, Bicheng
    Chen, Zhengsheng
    Luo, Lei
    Qian, Hui
    Fu, Qing-Ling
    Wang, Qian
    Zheng, Lei
    Wang, Yang
    INTERDISCIPLINARY MEDICINE, 2023, 1 (01):
  • [42] Roles of Regulatory T Cell-Derived Extracellular Vesicles in Human Diseases
    Lin, Can
    Guo, Jihua
    Jia, Rong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [43] Differential metabolism of clinically-relevant progestogens in cell lines and tissue: Implications for biological mechanisms
    Skosana, Salndave B.
    Woodland, John G.
    Cartwright, Meghan
    Enfield, Kim
    Komane, Maleshigo
    Louw-du Toit, Renate
    van der Spuy, Zephne
    Avenant, Chanel
    Africander, Donita
    Storbeck, Karl-Heinz
    Hapgood, Janet P.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2019, 189 : 145 - 153
  • [44] Engineering cell-derived matrices with controlled 3D architectures for pathophysiological studies
    Almici, Enrico
    Caballero, David
    Montero Boronat, Joan
    Samitier Marti, Josep
    CELL-DERIVED MATRICES, PT A, 2020, 156 : 161 - +
  • [45] Regulation of cell adhesion and migration by cell-derived matrices
    Kutys, Matthew L.
    Doyle, Andrew D.
    Yamada, Kenneth M.
    EXPERIMENTAL CELL RESEARCH, 2013, 319 (16) : 2434 - 2439
  • [46] A clinically relevant large-scale biomanufacturing workflow to produce natural killer cells and natural killer cell-derived extracellular vesicles for cancer immunotherapy
    St-Denis-Bissonnette, Frederic
    Cummings, Sarah E.
    Qiu, Shirley
    Stalker, Andrew
    Muradia, Gauri
    Mehic, Jelica
    Mediratta, Karan
    Kaczmarek, Shelby
    Burger, Dylan
    Lee, Seung-Hwan
    Wang, Lisheng
    Lavoie, Jessie R.
    JOURNAL OF EXTRACELLULAR VESICLES, 2023, 12 (12)
  • [47] IN VITRO DEVELOPMENT OF 3D CELL-DERIVED EXTRACELLULAR MATRICES FOR COLORECTAL CANCER MODELING
    Rubi-Sans, Gerard
    Nyga, Agata
    Camps, Jordi
    Perez-Amodio, Soledad
    Mateos-Timoneda, Miguel A.
    Engel, Elisabeth
    Blanco-Fernandez, Barbara
    TISSUE ENGINEERING PART A, 2022, 28 : S217 - S217
  • [48] Cell-derived Matrices - Part B Preface
    Caballero, David
    Kundu, Subhas C.
    Reis, Rui L.
    CELL-DERIVED MATRICES, PT B, 2020, 157 : XV - XV
  • [49] A comparison of clinically relevant sources of mesenchymal stem cell-derived exosomes: Bone marrow and amniotic fluid
    Tracy, Sarah A.
    Ahmed, Azra
    Tigges, John C.
    Ericsson, Maria
    Pal, Anoop K.
    Zurakowski, David
    Fauza, Dario O.
    JOURNAL OF PEDIATRIC SURGERY, 2019, 54 (01) : 86 - 90
  • [50] Emerging Strategies for Optimizing Cell-Derived Decellularized Extracellular Matrix Scaffolds in Tissue Engineering
    Chen, Huan
    Zhang, Siyi
    Fu, Yao
    ADVANCED ENGINEERING MATERIALS, 2024, 26 (09)